Page last updated: 2024-08-21

3-hydroxyflavone and Cardiac Diseases

3-hydroxyflavone has been researched along with Cardiac Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, G; Dai, X; Feng, J; Ge, C; Hu, LF; Kuang, Q; Lai, L; Li, H; Long, T; Sun, Y; Tan, J; Tang, T; Xiong, M; Xu, M; Yang, Q; Yi, C; Zhan, J; Zhong, S1
Chang, L; Dai, J; Fu, Y; He, Q; Luo, P; Shao, J; Wang, J; Weng, Q; Yang, B; Yang, X; Zhu, H1

Other Studies

2 other study(ies) available for 3-hydroxyflavone and Cardiac Diseases

ArticleYear
Oral flavonoid fisetin treatment protects against prolonged high-fat-diet-induced cardiac dysfunction by regulation of multicombined signaling.
    The Journal of nutritional biochemistry, 2020, Volume: 77

    Topics: Animals; Diet, High-Fat; Disease Models, Animal; Dyslipidemias; Echocardiography; Fibrosis; Flavonoids; Flavonols; Glucose Tolerance Test; Heart; Heart Diseases; Inflammation; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Rats; Rats, Wistar; Signal Transduction

2020
Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin.
    Oncotarget, 2015, Feb-20, Volume: 6, Issue:5

    Topics: Animals; Animals, Newborn; Antibiotics, Antineoplastic; Apoptosis; Cell Proliferation; Cytoprotection; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Doxorubicin; Flavonols; Heart Diseases; HL-60 Cells; Humans; K562 Cells; Lymphoma, Large B-Cell, Diffuse; Mice, Inbred BALB C; Mice, Inbred ICR; Myocytes, Cardiac; Nerve Tissue Proteins; Oxidative Stress; Protective Agents; Proto-Oncogene Proteins c-mdm2; Rats; Rats, Sprague-Dawley; Signal Transduction; Time Factors; Tumor Burden; Tumor Suppressor Protein p53; U937 Cells; Xenograft Model Antitumor Assays

2015